Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3393
Revised: May 11, 2024
Accepted: May 24, 2024
Published online: August 15, 2024
Processing time: 123 Days and 7.1 Hours
Colorectal cancer is one of the predominant tumors in the world, primarily generated by a progression from polyp to cancer which can last several years, giving a great opportunity to the scientific community for its prevention by screening programs that can be done with invasive and non-invasive tests. In this issue, Lopes et al show us an excellent review of screening, its options, its advantages and disadvantages.
Core Tip: Colorectal cancer can be prevented in more than 90% of cases, but for this it is very important to have screening programs that detect and treat the disease in time. Although there are multiple tests and probably non-invasive serological tests will be the ones used in the future. Two tests are mainly used on a regular basis in the world: Fecal immunochemical test and colonoscopy and we should focus our attention on them when deciding. In this editorial we will discuss these aspects.